Introduction
Trimethoprim inhibits chromosomally-encoded dihydrofolate reductase (DHFR) required for bacterial metabolism of folic acid (Smith and Amyes, 1984) . High-level plasmid-mediated resistance to trimethoprim (Tp'(HJ in Escherichia coli involves the production of an insusceptible target enzyme which allows the inhibited metabolic step to be bypassed (Amyes and Smith, 1974) . Resistance to trimethoprim has also been encountered in multiresistant strains of Staphylococcus aureus (MRSA) and coagulase-negative staphylococci isolated in Australia and elsewhere (Hamilton-Miller et al., 1981 ; Lyon et al., 1983; Richardson, 1983; Town-send et al., 1984; Archer et al., 1986) . Resistance to high concentrations of trimethoprim (2 1000 mg/L) in c. 50% of Australian isolates of MRSA is mediated by the 28.4-Kb plasmid pSKl which also encodes resistance to acriflavine, quaternary ammonium compounds and the aminoglycosides gentamicin, tobramycin and kanamycin (Gillespie et al., 1986; . The trimethoprimresistance gene from pSK 1, designated d f A , encodes the production of a trimethoprim-resistant dihydrofolate reductase (Young et al., 1987) . This plasmid-encoded enzyme, the first to be characterised in staphylococci, differs from all previously characterised plasmid-encoded dihydrofolate reductases and we have designated it type S1 (Young et al., 1987) .
The spread of resistance to antimicrobial agents in nature may be accomplished by the transfer of resistance determinants between S. aureus and coagulase-negative staphylococci (Lacey, 1975) . In continuance of our investigations into the relevance of this hypothesis to the emergence and spread of MRSA in Australian hospitals (Tennent et al., 1984 , we have compared the genetic and molecular characteristics of the trimethoprim resistance exhibited by epidemiologically-related isolates of MRSA and coagulase-negative staphylococci and have characterised the trimethoprimresistant dihydrofolate reductases produced by these strains.
Materials and methods

Bacterial strains and plasmids
Clinical isolates of S . aureus and coagulase-negative staphylococci were selected from a collection of multiresistant strains obtained from Australian hospitals between 1979 and 1982. The coagulase-negative staphylococci were identified as either S. epidermidis (1 14 strains) or as 'other coagulase-negative staphylococci' (S. haemolyticus, S. saprophyticus, S. simulans, S. warneri, S. horninis; 50 strains) on the basis of phosphatase activity and aerobic production of acid from maltose, mannitol, sucrose, or trehalose (Kloos and Schleifer, 1975) . Two strains of 'other coagulase-negative staphylococci' that were highly resistant to trimethoprim were identified as S. hominis type I by the API Staph system. S. aureus strains carrying plasmids for use as size standards, and plasmid-free strains of S. aureus (SA113, SK982) used as recipients in DNA transfer experiments, have been described previously (Lyon et al., 19846; Tennent et al., 1986) . A description of the S. aureus plasmids and strains examined in this study is presented in table I; plasmid pSKl is representative of a family of S. aureus multiresistance plasmids which range in size from 20 to 42 Kb and principally encode resistance to antiseptics or disinfectants and to aminoglycoside antibiotics (Gillespie et al., 19876) . Methods for the curing of plasmids and for the construction of the S. aureus-E. coli hybrid plasmid pSK407 from pSK 1 have been described elsewhere (Lyon et al., 1983 and .
General procedures
Trimethoprim sensitivity and minimum inhibitory concentrations (MICs) were determined on Diagnostic Sensitivity Test Agar (Oxoid) supplemented with 5% defibrinated horse blood lysed with saponin. The methods used for testing sensitivity to other antimicrobial agents, for transformation of plasmid DNA, and for plasmid elimination, were as described previously (Lyon et al., 1983; Gillespie et al., 1984) . The transfer of plasmid DNA in mixed culture was performed as described by McDonnell et al. (1983) .
DNA manipulation procedures
Isolation of plasmid DNA, digestion with the restriction enzymes BglII, EcoRI, EcoRV, HindIII, and HpaII (New England Biolabs, Inc., Beverley, MA, USA), and agarose gel electrophoresis, were performed as previously described (Tennent et al., 1984) . HindIII digests of lambda DNA were used as standards; fragment sizes in kilobase pairs (Kb) were as published (Daniels et al., 1983) . DNA was transferred to nitrocellulose for hybridisation analysis by the bidirectional procedure of Smith and Summers (1980) . A 0.9-Kb EcoRI-EcoRV DNA fragment, which spans the dfrA structural gene, was prepared b electroelution from pSK407, nick-translated with (a-P)dATP (1800 Ci/mmol) and hybridised under conditions of high stringency with nitrocellulose filters carrying target DNA, as described by Maniatis et al. (1982) . Washed and dried filters were exposed to Fuji RX film at -70°C for sufficient time to produce an acceptable autoradiograph.
I* Dihydrofolate reductase
DHFR was prepared from 3-L stationary-phase cultures grown in Brain Heart Infusion Broth (Oxoid) by the method of Young et al. (1987) . Enzyme activity was assayed by the method of Amyes and Smith (1974) and characterised as described previously (Young et al., 1987) .
Results
Trimethoprim resistance in S. aureus
Susceptibility tests of clinical strains of S. aureus revealed that plasmids in the same family as pSKl , such as pSK16, also conferred high-level resistance to trimethoprim (MIC > 1000 mg/L) on their hosts (table I) . Derivatives cured.of pSKl (strain SK553) or pSK16 (strain SK296) were no longer highly resistant to trimethoprim but were more resistant than S. aureus NCTC 6571. The level of trimethoprim resistance in SK553 was similar to that found with the clinical isolates of S . aureus that carried plasmids pSK9 and pSK14, and S. aureus strain SK434 that lacked a plasmid belonging to the pSK 1 family (table I) .
Plasmid location of the trimethoprim-resistance gene in S. aureus
The structural gene for Tpr(H) which has been localised to a 0.75-Kb sequence of DNA contained within the 2.75-Kb BglII fragment of pSKl (Lyon et al., 1986 ) is shown in fig. 1 . The S. aureus aminoglycoside-resistance plasmids pSK9 and pSK14 did not encode the Tp',,, phenotype although their resistance profiles were similar to those of pSKl and pSK16 (table I) * Some strains carry more than one plasmid; only the pSKl-family plasmid is described.
SK553 is a pSK1-cured derivative of SK529. $ SK296 is a pSK16-cured derivative of SK271. @ SK434 is a clinical isolate which lacks a pSKl-family plasmid.
plasmids pSK9 and pSK 14 were identical to pSK 1 except that deletions of 2.7 Kb and 4.0 Kb, respectively, had occurred in the region of these plasmids corresponding to the position of the dfrA gene ( fig.  1 ). Both deletions were found to overlap the BgZII site at 12.05 on the pSKl map and thus accounted for the distinct BgZII profiles of pSK9 and pSK14.
A 0.9-Kb EcoRI-EcoRV fragment of plasmid pSK407 (Lyon et al., 1986) , which maps between co-ordinates 13.55 and 14-45 on the pSKl map ( fig.  1 ) and consists almost entirely of the dfrA determinant, was used to probe the BgZII digests of the S. Hybridisation analysis of trimethoprim-resistant coagulase-nega t ive staphylococci Rapidly-isolated DNA from four of the Tp',,, strains of coagulase-negative staphylococci, and from one representative S. aureus strain harbouring pSKl (SK429), was analysed by agarose gel electrophoresis ( fig. 3A) , transferred to nitrocellulose and then hybridised with the radiolabelled 0.9-Kb EcoRI-EcoRV fragment from plasmid pSK407 ( fig. 3B) 
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Kb EcoRI-EcoRV DNA fragment of pSK407 was considered suitable for use as a dfrkspecific probe.
Tr imet hoprim resistance in coagulase-nega t ive staphylococci Screening Of 164 clinical isolates Of multiresistant coagulase-negative staphylococci showed that 7 1 strains (43%) were resistant to tr-methoprim 50 mg/L, For 63 (89%) ofthese 71 resistant strains, the MIC of trimethoprim was 100 mg/L, Whereas the MIC for the other eight (1 1%) isolates was hybridisation with the Tp'(,,-specific probe. (Lyon et al., 1983) . B. Autoradiograph of the gel in A after 3B, lane b), which were presumed to have corresponded to the covalently closed circular (ccc), open circular (oc) and linear forms of a 7.9-Kb plasmid present in this isolate, hybridised with the probe DNA. Plasmids of different sizes in strains SK76 (15.5 Kb) and SK400 (17.5 Kb), and the presumptive chromosomal material of SK683, also demonstrated homology with the dfrA-specific probe ( fig.  3B, lanes c, d, and e) .
Dihydrofolate reductases encoded by trirnethoprirnresistance genes
The plasmid-encoded dihydrofolate reductases from strains SK76, SK47 and SK400 were very similar to one another and to the chromosomallyencoded enzyme from strain SK683 (table 11) . However, the specific activity of the chromosomal dihydrofolate reductase from SK683 was very much lower than that from the other three strains. All four enzymes had properties similar to those of the type S1 dihydrofolate reductase encoded by S. aureus plasmid pSK 1, including a remarkably high affinity for methotrexate. The small variations in ID50 values for trimethoprim are unlikely to be significant, especially when they are considered in conjunction with the Ki results for trimethoprim. The type S1 dihydrofolate reductase differed from the chromosomal enzyme in S . aureus NCTC 6571 and was also distinct from the enzyme in the trimethoprim-sensitive S. epiderrnidis strain SK360 (table 11) .
Discussion
Over half the strains of MRSA isolated in Australia harbour a 20-42-Kb plasmid that belongs to a family of structurally-related plasmids which includes pSK 1, pSK4, pSK8, pSK9, pSK 14, pSK 16 and pSK17 (Gillespie et al., 1987b; Lyon et al., 1984a; Lyon and Skurray, unpublished data) . In this study, a 0.9-Kb fragment located within the 2-75-Kb BgZII fragment of pSKl was used as a dfrhspecific probe. Homologous fragments of 2.75 Kb were also present in the BgZII digestion profiles of other S . aureus plasmids to which the Tpr(H) phenotype had previously been assigned by plasmid elimination and transfer experiments. As expected, those S . aureus plasmids that did not mediate Tp',,) failed to hybridise with the probe DNA. On this basis, isolates of Tp' !,) coagulasenegative staphylococci were examined for the presence of DNA sequences homologous to the S . aureus Tp',,) determinant. Three isolates of coagulase-negative staphylococci carried plasmid DNA which hybridised with the probe DNA and, in a fourth strain, the probe bound to DNA which formed a band at the position appropriate to chromosomal DNA. The relatively low DHFR activity associated with this fourth strain suggests that the gene was located on a low copy-number replicon as would be expected for the chromosome. Together, these results suggest that an identical Tpr(H) determinant was present among some Australian isolates of S. aureus and coagulase-negative staphylococci and we believe this to be the first indication that the S . aureus dfrA determinant may be present at both plasmid and chromosomal loci in coagulase-negative staphylococci. The interspecies dissemination of such a Tp',,) determinant may have occurred by plasmid transfer. Archer et al. (1986) showed that conjugative . We have designated the putative trimethoprimresistance transposon Tn4003 and are presently screening DNA from the Tp' (H1 coagulase-negative staphylococci . for the presence of IS257 sequences. The trimethoprim-resistance gene of pSK 1 encodes the production of the type S1 dihydrofolate reductase which is quite unlike the plasmid enzymes of gram-negative bacteria (Young and Amyes, 1986; Young et al., 1987) . However, the degree of insusceptibility to trimethoprim of the type S 1 DHFR is very similar to the type 1 enzyme. The type I enzyme accounts for the majority of plasmidborne trimethoprim resistance in gram-negative organisms. The gene for this enzyme resides on a transposon (Barth et al., 1976) but the level of resistance to trimethoprim may also have some selective advantage. If this is so, the gene encoding the S1 enzyme may be equally successful in grampositive bacteria.
The presence of common, or closely related, trimethoprim-resistance determinants in S . aureus and coagulase-negative staphylococci strongly suggests that interspecies exchange of genetic material has occurred in vivo among Australian isolates of staphylococci. How such transfer occurs, and which species acts as the source of resistance determinants, are unknown. The transfer of antibiotic resistance from coagulase-negative staphylococci to S. aureus on skin in vivo (Jaffe etal., 1980; Naidoo and Noble, 1981) suggests that transfer may have occurred in the natural habitat of these organisms under selective pressure of antimicrobial use.
